Fortrea Holdings IncNASDAQ:FTRE
- LAST PRICE16.5800
- TODAY'S CHANGE (%)-0.2900 (-1.7190%)
- Bid / Lots16.6400/ 8
- Ask / Lots16.8600/ 8
- Open / Previous Close16.7300 / 16.8700
- Day Range
- 52 Week Range
- Volume6,740
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FTRE |
|---|---|---|
| 09:32 ET | 5108 | 16.76 |
| 09:33 ET | 1091 | 16.715 |
| 09:35 ET | 100 | 16.58 |
Yesterday
Nov 2, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE, from 12:00PM ET on Saturday Nov 02, 2024 by Dow Jones
12:00PM ET on Saturday Nov 02, 2024 by Dow Jones
Oct 31, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE, from 4:17PM ET on Thursday Oct 31, 2024 by Dow Jones
4:17PM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 29, 2024
FTRE STOCK ALERT: Levi & Korsinsky Notifies Fortrea Holdings Inc. Investors of an Ongoing Investigation, from 1:01PM ET on Tuesday Oct 29, 2024 by Dow Jones
1:01PM ET on Tuesday Oct 29, 2024 by Dow JonesSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE, from 12:05PM ET on Tuesday Oct 29, 2024 by Dow Jones
12:05PM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fortrea Holdings Inc | 1.5B | -6.5x | --- |
Alkermes Plc | 4.3B | 9.4x | --- |
P3 Health Partners Inc | 127.6M | -0.6x | --- |
Novavax Inc | 1.5B | -3.3x | --- |
Charles River Laboratories International Inc | 9.4B | 21.6x | +15.57% |
Qiagen NV | 9.8B | 136.9x | +12.66% |
Company Information
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Contact Information
- Headquarters
- 8 Moore DriveDURHAM, NC, United States 27709
- Phone
- ---
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer
- Thomas Pike
- Chief Financial Officer
- Jill Mcconnell
- Chief Operating Officer President - Clinical Services
- Mark Morais
- Lead Independent Director
- R. Andrew Eckert
- Director
- Machelle Sanders
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $2.9B |
Shares Outstanding | 89.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.56 |
Book Value | $19.30 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
